Figure 1: Results of the analysis of PtNTT2 using Phobius.
The 30 first amino acids are clearly recognized as a signal peptide. Ten transmembrane domains are predicted.
Line 15: | Line 15: | ||
<div class="content"> | <div class="content"> | ||
<h3>Short Summary</h3> | <h3>Short Summary</h3> | ||
− | <article> | + | <div class="article"> |
− | Uptake of unnatural nucleoside triphosphates is of major importance for the development of a semisynthetic organism. The nucleotide transporter <i>Pt</i>NTT2 from the algae <i>Phaeodactylum tricornutum</i> was successfully expressed in <i>Escherichia coli</i> BL21(DE3) and comprehensively characterized. We designed and tested five different variants of the transporter and we demonstrated that certain variants of the transporter can facilitate uptake of iso-dC<sup>m</sup>TP and iso-dGTP from the media. | + | Uptake of unnatural nucleoside triphosphates is of <a href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Project/unnatural_base_pair/uptake_and_biosynthesis">major importance</a> for the development of a semisynthetic organism. The nucleotide transporter <i>Pt</i>NTT2 from the algae <i>Phaeodactylum tricornutum</i> was successfully expressed in <i>Escherichia coli</i> BL21(DE3) and comprehensively characterized. We designed and tested five different variants of the transporter and we demonstrated that certain variants of the transporter can facilitate uptake of <a href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Project/unnatural_base_pair/unnatural_base_pairs">iso-dC<sup>m</sup>TP and iso-dGTP</a> from the media. |
</article> | </article> | ||
</div> | </div> | ||
Line 155: | Line 155: | ||
<h3> Cultivations of the Different <i>Pt</i>NTT2 Variants </h3> | <h3> Cultivations of the Different <i>Pt</i>NTT2 Variants </h3> | ||
<article>Given that Zhang <i><i>et al.</i></i>, 2017 reported some kind of toxicity resulting from the N-terminal sequence of <i>Pt</i>NTT2, we first investigated if we could also observe the same toxicity associated with the N-terminal sequence. We also tested whether our own versions of the transporter results in better growth and reduced toxicity compared to the native transporter. Therefore, after cloning the plasmids in <i>E. coli</i> DH5α and verifying the correct assembly via sequencing, all plasmids were transformed into <i>E. coli</i> BL21(DE3). The presence of the correct plasmids was again verified by colony PCR. | <article>Given that Zhang <i><i>et al.</i></i>, 2017 reported some kind of toxicity resulting from the N-terminal sequence of <i>Pt</i>NTT2, we first investigated if we could also observe the same toxicity associated with the N-terminal sequence. We also tested whether our own versions of the transporter results in better growth and reduced toxicity compared to the native transporter. Therefore, after cloning the plasmids in <i>E. coli</i> DH5α and verifying the correct assembly via sequencing, all plasmids were transformed into <i>E. coli</i> BL21(DE3). The presence of the correct plasmids was again verified by colony PCR. | ||
− | The first cultivations were carried out in shake flasks in LB media. A total cultivation volume of 50 mL was used. The cultures were incubated at 37 °C and 180 rpm. All cultures were inoculated with an OD<sub>600</sub> of 0.01. OD<sub>600</sub> was measured every hour during lag and stationary phase and every 30 minutes during the exponential phase. The optical density was measured using an Eppendorf Photometer and standard cuvettes. <i>E. coli</i> BL21(DE3) without a plasmid and <i>E. coli</i> BL21(DE3) harboring pSB1C3-PtNTT2 were used as negative controls. Two biological replicates of each strain were tested and three technical replicates were measured for each timepoint. | + | The first cultivations were carried out in shake flasks in LB media. A total cultivation volume of 50 mL was used. The cultures were incubated at 37 °C and 180 rpm in 500 mL shake flasks. All cultures were inoculated with an OD<sub>600</sub> of 0.01. OD<sub>600</sub> was measured every hour during lag and stationary phase and every 30 minutes during the exponential phase. The optical density was measured using an Eppendorf Photometer and standard cuvettes. <i>E. coli</i> BL21(DE3) without a plasmid and <i>E. coli</i> BL21(DE3) harboring pSB1C3-PtNTT2 were used as negative controls. Two biological replicates of each strain were tested and three technical replicates were measured for each timepoint. |
Line 226: | Line 226: | ||
<br> | <br> | ||
− | To determine the maximum specific growth rate (µ<sub>max</sub>), the natural logarithm of the OD<sub>600</sub> values was plotted against the cultivation time. The slope of the linear regression through the exponential phase gives µ<sub>max</sub>. The graphical determination of | + | To determine the maximum specific growth rate (µ<sub>max</sub>), the natural logarithm of the OD<sub>600</sub> values was plotted against the cultivation time. The slope of the linear regression through the exponential phase gives µ<sub>max</sub>. The graphical determination of µ<sub>max</sub> for the shake flask cultivation is shown in Figure 4 |
<div class="figure seventy"> | <div class="figure seventy"> | ||
Line 686: | Line 686: | ||
<p class="figure subtitle"><b>Figure 13: Graphical determination of the maximum specific growth rates of all cultivations performed in MOPS media and 1 mM ATP. </b><br> </p> | <p class="figure subtitle"><b>Figure 13: Graphical determination of the maximum specific growth rates of all cultivations performed in MOPS media and 1 mM ATP. </b><br> </p> | ||
</div> | </div> | ||
− | The determined values for | + | The determined values for µ<sub>max</sub> and the minimal doubling times are shown in Table 9. |
<p class="figure subtitle"><b>Table 9: Maximum specific growth rates and minimal doubling times of the cultivations in MOPS media with 1 mM ATP.</b><br> </p> | <p class="figure subtitle"><b>Table 9: Maximum specific growth rates and minimal doubling times of the cultivations in MOPS media with 1 mM ATP.</b><br> </p> | ||
Line 808: | Line 808: | ||
<article> | <article> | ||
− | To investigate the subcellular localization of the different <i>Pt</i>NTT2 variants, GFP fusion proteins were constructed as listed in Table 1. Each <i>Pt</i>NTT2 variant was tagged with a cMyc epitope tag as a linker and GFP (BBa_E0040). The cells were cultivated and prepared for microscopy as described in the methods section. Microscopy was performed using the Zeiss LSM 700. The pictures shown in Figure 19 were taken at 100x magnification and clearly show the subcellular localization of the different <i>Pt</i>NTT2 variants. | + | To investigate the subcellular localization of the different <i>Pt</i>NTT2 variants, GFP fusion proteins were constructed as listed in Table 1. Each <i>Pt</i>NTT2 variant was tagged with a cMyc epitope tag as a linker and GFP (BBa_E0040). The cells were cultivated and prepared for microscopy as described in the <a href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Notebook/Methods">methods section</a>. Microscopy was performed using the Zeiss LSM 700. The pictures shown in Figure 19 were taken at 100x magnification and clearly show the subcellular localization of the different <i>Pt</i>NTT2 variants. |
<div class="figure large"> | <div class="figure large"> | ||
<img class="figure image" src="https://static.igem.org/mediawiki/2017/a/a1/T--Bielefeld-CeBiTec--microscopy.jpeg"> | <img class="figure image" src="https://static.igem.org/mediawiki/2017/a/a1/T--Bielefeld-CeBiTec--microscopy.jpeg"> | ||
− | <p class="figure subtitle"><b>Figure 19: Confocal laser scanning microscopy of the different <i>Pt</i>NTT2 variants fused to GFP (BBa_E0040). </b> The pictures were taken with 100x magnification and show from <b>A</b> to <b>E</b>: | + | <p class="figure subtitle"><b>Figure 19: Confocal laser scanning microscopy of the different <i>Pt</i>NTT2 variants fused to GFP (BBa_E0040). </b> The pictures were taken with 100x magnification and show from <b>A</b> to <b>E</b>: <i>E. coli</i> BL21(DE3) pSB1C3-PlacUV5-PtNTT2, <i>E. coli</i> BL21(DE3) pSB1C3-PlacUV5-PtNTT2(66-575), <i>E. coli</i> BL21(DE3) pSB1C3-PlacUV5-PtNTT2(31-575), <i>E. coli</i> BL21(DE3) pSB1C3-PlacUV5-pelB-SP-PtNTT2 and <i>E. coli</i> BL21(DE3) pSB1C3-PlacUV5-TAT-SP-PtNTT2.</p> |
</div> | </div> | ||
All <i>Pt</i>NTT2 variants can be localized within the membrane, since the fluorescence signals of the GFP tag are concentrated there. Judging from the pictures, the variant with the pelB signal peptide is weakly integrated into the inner membrane, which would explain the good growth characteristics and the weak functionality of this variant. The TAT-signal peptide variant, which showed bad growth characteristics and no substantial function, seems to be located within the cell envelope nonetheless. Given that peptides containing the TAT signal peptide are usually folded within the cytoplasm and then secreted via the twin-arginine translocation pathway, this could be a possible explanation for the non-existent function of the TAT variant. All other variants that also showed a detectable function are successfully integrated into the membrane. The variants without a signal peptide are also located within the membrane, which is not surprising, given that the integration of membrane proteins does not necessarily require a signal peptide (Facey and Kuhn, 2004) . <i>Pt</i>NTT2(66-575) seems to be better integrated into the membrane than any other variant. The native <i>Pt</i>NTT2, and <i>Pt</i>NTT2(31-575) are integrated in a similar scale, but a little bit weaker compared to <i>Pt</i>NTT2(66-575). These results are consistent with the results of the verification of the function of <i>Pt</i>NTT2, since all variants that showed a relative beneficial effect and also the highest AMP concentrations in the supernatant do integrate the transporter into the membrane. For the TAT signal peptide variant, it is most likely that the transporter is integrated incorrectly, leading to a correct subcellular localization while lacking the correct function. | All <i>Pt</i>NTT2 variants can be localized within the membrane, since the fluorescence signals of the GFP tag are concentrated there. Judging from the pictures, the variant with the pelB signal peptide is weakly integrated into the inner membrane, which would explain the good growth characteristics and the weak functionality of this variant. The TAT-signal peptide variant, which showed bad growth characteristics and no substantial function, seems to be located within the cell envelope nonetheless. Given that peptides containing the TAT signal peptide are usually folded within the cytoplasm and then secreted via the twin-arginine translocation pathway, this could be a possible explanation for the non-existent function of the TAT variant. All other variants that also showed a detectable function are successfully integrated into the membrane. The variants without a signal peptide are also located within the membrane, which is not surprising, given that the integration of membrane proteins does not necessarily require a signal peptide (Facey and Kuhn, 2004) . <i>Pt</i>NTT2(66-575) seems to be better integrated into the membrane than any other variant. The native <i>Pt</i>NTT2, and <i>Pt</i>NTT2(31-575) are integrated in a similar scale, but a little bit weaker compared to <i>Pt</i>NTT2(66-575). These results are consistent with the results of the verification of the function of <i>Pt</i>NTT2, since all variants that showed a relative beneficial effect and also the highest AMP concentrations in the supernatant do integrate the transporter into the membrane. For the TAT signal peptide variant, it is most likely that the transporter is integrated incorrectly, leading to a correct subcellular localization while lacking the correct function. | ||
Line 847: | Line 847: | ||
</div> | </div> | ||
− | In a second approach, the cells were lysed using a nitrogen cooled Precellys Homogenizer. After three cycles, cells were centrifuged at 4 °C and the membrane fraction was isolated as described in the methods section. After boiling the membrane fraction, the samples were loaded onto two SDS PAGEs, one of which was consequently used for a Western Blot, if the fusion proteins were used. For the Western Blot, two different antibodies were tested, an anti-GFP antibody and an anti-cMyc antibody. Figure 22 shows the SDS-PAGE after isolation of the membrane fraction. Again, no clear difference between the negative controls and the samples could be observed around 90 kDa. | + | In a second approach, the cells were lysed using a nitrogen cooled Precellys Homogenizer. After three cycles, cells were centrifuged at 4 °C and the membrane fraction was isolated as described in the <a href="https://2017.igem.org/Team:Bielefeld-CeBiTec/Notebook/Methods">methods section</a>. After boiling the membrane fraction, the samples were loaded onto two SDS PAGEs, one of which was consequently used for a Western Blot, if the fusion proteins were used. For the Western Blot, two different antibodies were tested, an anti-GFP antibody and an anti-cMyc antibody. Figure 22 shows the SDS-PAGE after isolation of the membrane fraction. Again, no clear difference between the negative controls and the samples could be observed around 90 kDa. |
<div class="figure sixty"> | <div class="figure sixty"> |
Latest revision as of 03:26, 2 November 2017
Short Summary
Computational Analysis of PtNTT2
Plasmid Design
Figure 2: Schematic overview of the design of the different transporter variants. The lacUV5 promotor was used together with a strong RBS (BBa_B0034) for all parts. All variants except for pSB1C3-PtNTT2 were also tagged with GFP (BBa_E0040). cMyc was used as a linker (BBa_K2201181).
Table 1: Designed and cloned plasmids for the analysis and characterization of PtNTT2.
Plasmid Name | BioBrick Number | Characteristics |
---|---|---|
pSB1C3-PtNTT2 | BBa_K2201004 | Only the cds |
pSB1C3-PlacUV5-PtNTT2 | BBa_K2201000 | cds with lacUV5 promotor and strong RBS (BBa_B0034) |
pSB1C3-PlacUV5-PtNTT2(66-575) | BBa_K2201001 | cds with lacUV5 promotor and a strong RBS (BBa_B0034) |
pSB1C3-PlacUV5-PtNTT2(31-575) | BBa_K2201005 | cds with lacUV5 promotor and a strong RBS (BBa_B0034), truncated version lacking the first 30 amino acids |
pSB1C3-PlacUV5-pelB-SP-PtNTT2 | BBa_K2201006 | cds with lacUV5 promotor and a strong RBS (BBa_B0034), native signal peptide replaced with the pelB signal peptide |
pSB1C3-PlacUV5-TAT-SP-PtNTT2 | BBa_K2201007 | cds with lacUV5 promotor and a strong RBS (BBa_B0034), native signal peptide replaced with a TAT signal peptide |
pSB1C3-PlacUV5-PtNTT2-GFP | BBa_K2201002 | Fusion protein of BBa_ K2201000 with GFP (BBa_E0040), Myc epitope tag as linker (BBa_K2201181) |
pSB1C3-PlacUV5-PtNTT2(66-575)-GFP | BBa_K2201003 | Fusion protein of BBa_ K2201001 with GFP (BBa_E0040), Myc epitope tag as linker (BBa_K2201181) |
pSB1C3-PlacUV5-PtNTT2(31-575)-GFP | BBa_K2201011 | Fusion protein of BBa_K2201005 with GFP (BBa_E0040), Myc epitope tag as linker (BBa_K2201181) |
pSB1C3-PlacUV5-pelB-SP-PtNTT2-GFP | BBa_K2201012 | Fusion protein of BBa_K2201006 with GFP (BBa_E0040), Myc epitope tag as linker (BBa_K2201181) |
pSB1C3-PlacUV5-TAT-SP-PtNTT2-GFP | BBa_K2201013 | Fusion protein of BBa_K2201007 with GFP (BBa_E0040), Myc epitope tag as linker (BBa_K2201181) |
Cultivations of the Different PtNTT2 Variants
Figure 3: Shake flask cultivation of all PtNTT2 variants. E. coli BL21(DE3) and E. coli BL21(DE3) pSB1C3-PtNTT2 (BBa_K2201004), not expressing PtNTT2, were used as negative controls. Two biological replicates of each strain were cultivated and three technical replicates taken for each measurement. A clear difference in the growth rates can be observed, with E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2 (BBa_K2201000) and E. coli BL21(DE3) pSB1C3-PlacUV5-TAT-SP-PtNTT2 (BBa_K2201007) showing the weakest growth. Both strains also show the longest lag phase, which is nearly twice as long as the lag phase of E. coli BL21(DE3). E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2(66-575) (BBa_K2201001) and E. coli BL21(DE3) pSB1C3-PlacUV5-pelB-SP-PtNTT2 (BBa_K2201006) show the best growth of all PtNTT2 variants, reaching the highest OD600.
Table 2: Final OD600 of all cultures. The highest OD600 was reached by the wildtype E. coli BL21(DE3), the lowest by E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2.
Strain | Final OD600 [-] | |
---|---|---|
E. coli BL21(DE3) | 5.178 ± 0.046 | |
E. coli BL21(DE3) pSB1C3-PtNTT2 | 4.638 ± 0.029 | |
E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2 | 2.499 ± 0.134 | |
E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2(66-575) | 4.397 ± 0.062 | |
E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2(31-575) | 3.802 ± 0.135 | |
E. coli BL21(DE3) pSB1C3-PlacUV5-pelB-SP-PtNTT2 | 4.171 ± 0.051 | |
E. coli BL21(DE3) pSB1C3-PlacUV5-TAT-SP-PtNTT2 | 2.735 ± 0.150 |
To determine the maximum specific growth rate (µmax), the natural logarithm of the OD600 values was plotted against the cultivation time. The slope of the linear regression through the exponential phase gives µmax. The graphical determination of µmax for the shake flask cultivation is shown in Figure 4
Figure 4: Graphical determination of µmax. The highest specific growth rate was determined for each culture by plotting the natural logarithm of OD600 against the cultivation time. The slope of the linear regression through the exponential phase gives µmax.
(1)
With td being the doubling time in hours and µ the specific growth rate in h-1. The maximum specific growth rates and minimal doubling times are show in Table 3 for all cultures.
Table 3: Maximum specific growth rates and minimum doubling times for all cultures.
Strain | µmax [h-1] | td [h] | |
---|---|---|---|
E. coli BL21(DE3) | 1.201 ± 0.070 | 0.577 ± 0.058 | |
E. coli BL21(DE3) pSB1C3-PtNTT2 | 1.212 ± 0.029 | 0.572 ± 0.024 | |
E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2 | 0.978 ± 0.033 | 0.709 ± 0.034 | |
E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2(66-575) | 1.194 ± 0.026 | 0.581 ± 0.022 | |
E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2(31-575) | 1.143 ± 0.045 | 0.606 ± 0.039 | |
E. coli BL21(DE3) pSB1C3-PlacUV5-pelB-SP-PtNTT2 | 1.189 ± 0.028 | 0.583 ± 0.024 | |
E. coli BL21(DE3) pSB1C3-PlacUV5-TAT-SP-PtNTT2 | 0.946 ± 0.030 | 0.733 ± 0.032 |
These results clearly show that expression of PtNTT2 leads to a reduced final cell density and slower growth. Furthermore, the different variants of PtNTT2 differ highly, indicating that some variants of PtNTT2 negatively affect the growth rate and final cell density.
Microcultivations of the Different PtNTT2 Variants
Figure 5: Microcultivation of all PtNTT2 variantsE. coli BL21(DE3) and E. coli BL21(DE3) pSB1C3-PtNTT2 (BBa_K2201004) were again used as negative controls. The same growth pattern as in the shake flask cultivation can be observed, with E. coli BL21(DE3) pSB1C3-PlacUV5-pelB-SP-PtNTT2, E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2(66-575) reaching the highest ODs, followed by E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2(31-575), E. coli BL21(DE3) pSB1C3-PlacUV5-TAT-SP-PtNTT2 and E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2.
Therefore, we were able to demonstrate that the results of the shake flask cultivations can be transferred to a smaller format, such as a micro cultivation in 1 mL. The reproduction of the results in a 50 times smaller volume is important for further experiments.
Table 4: Final OD600 of all cultures.
The highest OD600 was reached by the wildtype E. coli BL21(DE3) with 5,487 ± 0.038, the lowest by E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2 with 1.623 ± 0.481.
Strain | Final OD600 [-] | |
---|---|---|
E. coli BL21(DE3) | 5.487 ± 0.038 | |
E. coli BL21(DE3) pSB1C3-PtNTT2 | 4.337 ± 0.010 | |
E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2 | 1.623 ± 0.481 | |
E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2(66-575) | 4.035 ± 0.051 | |
E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2(31-575) | 3.865 ± 0.008 | |
E. coli BL21(DE3) pSB1C3-PlacUV5-pelB-SP-PtNTT2 | 4.110 ± 0.005 | |
E. coli BL21(DE3) pSB1C3-PlacUV5-TAT-SP-PtNTT2 | 2.280 ± 0.337 |
Like for the shake flask cultivation, µmax was determined graphically (Figure 6). Bases on the obtained values, the minimum doubling time was calculated. The results are summarized in Table 5.
Figure 6: Graphical determination of the maximum specific growth rate µmax for the microcultivations.
Table 5: Maximum specific growth rate and minimum doubling time for all cultures cultivated in 12 well plates.
Strain | µmax [h-1] | td [h] | |
---|---|---|---|
E. coli BL21(DE3) | 1.059 ± 0.143 | 0.655 ± 0.135 | |
E. coli BL21(DE3) pSB1C3-PtNTT2 | 1.016 ± 0.133 | 0.682 ± 0.131 | |
E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2 | 0.829 ± 0.071 | 0.836 ± 0.086 | |
E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2(66-575) | 1.023 ± 0.105 | 0.678 ± 0.103 | |
E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2(31-575) | 1.021 ± 0.096 | 0.679 ± 0.094 | |
E. coli BL21(DE3) pSB1C3-PlacUV5-pelB-SP-PtNTT2 | 1.047 ± 0.097 | 0.662 ± 0.093 | |
E. coli BL21(DE3) pSB1C3-PlacUV5-TAT-SP-PtNTT2 | 0.924 ± 0.113 | 0.750 ± 0.122 |
To investigate the effect of smaller well plates, a cultivation of two of our strains was performed by the iGEM team UNIFI from Florence, Italy. The team cultivated E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2 and E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2(66-575) in a 96 well plate. LB media was used as a reference. The cultivation was performed at 37 °C and 130 rpm in 3 mL of LB media. Three biological replicates were cultivated and measured at each time point. The results are shown in Figure 7.
Figure 7: Microcultivation in a 96 well plate performed by iGEM team UNIFI from Florence, Italy.
E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2 and E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2(66-575) were cultivated in a total volume of 3 mL at 37 °C and 130 rpm. The growth difference between the two strains observed in previous cultivations could also be observed in this experiment carried out by the team from Florence. E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2 reached a final OD600 of 0.329 ± 0.037 while E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2(66-575) reached a final OD600 of 0.664 ± 0.033.
Figure 8: Graphical determination of the maximum specific growth rates for the cultivations carried out in 96 well plates by the iGEM team UNIFI.
Table 6: Maximum specific growth rate and minimum doubling time for all cultures cultivated in 12 well plates.
Strain | µmax [h-1] | td [h] | |
---|---|---|---|
E. coli BL21(DE3) | 0.042 ± 0.004 | 16.504 ± 0.095 | |
E. coli BL21(DE3) pSB1C3-PtNTT2 | 0.110 ± 0.002 | 6.301 ± 0.018 |
Verification of the Function of PtNTT2
Under phosphate starvation, E. coli secretes phosphatases to utilize the phosphates from nucleotides as phosphate source. On the other hand, cells expressing PtNTT2 and integrating it into the inner membrane should be able to take up nucleoside triphosphates directly. By taking up nucleoside triphosphates directly from the media, the cells can directly take up three phosphates and the nucleobase. Given that the uptake of NTPs by PtNTT2 is facilitated by counter exchange of ATP, ATP is exported and consequently converted to AMP by extracellular phosphatases.
Figure 9: Proposed function of PtNTT2. . A) ATP is exported in presence of the unnatural nucleotides iso-dCmTP and iso-dGTP, leading to a constant loss of ATP, negatively influencing growth. B) If the media is supplemented with ATP in slightly higher concentrations than the intracellular concentration, ATP is likely taken up in exchange for ATP, ADP as well as other NTPs. A beneficial effect of expression of the transporter on the growth of the cells is achieved due to a small net uptake of ATP.C) In case of much higher extracellular concentrations compared to the intracellular concentration of ATP, ATP will be taken up efficiently in exchange for NTPs, ADP and AMP. This would lead to a net uptake of ATP, but a net loss of NTPs, leading to reduced growth.
Figure 9 shows the proposed function of PtNTT2. In presence of the unnatural nucleotides iso-dCmTP and iso-dGTP, ATP is exported. Therefore, uptake of iso-dCmTP and iso-dGTP leads to a constant loss of ATP, negatively influencing growth. If the media is supplemented with ATP in slightly higher concentrations than the intracellular concentration, ATP is likely taken up in exchange for ATP, ADP as well as other NTPs. This would lead to a small net uptake of ATP, and therefore to a beneficial effect of expression of the transporter on the growth of the cells. In case of much higher extracellular concentrations compared to the intracellular concentration of ATP, ATP will be taken up efficiently in exchange for NTPs, ADP and AMP. This would lead to a net uptake of ATP, but a net loss of NTPs, leading to reduced growth. For the first part of the experiment, two sets of cultivations were carried out in parallel. All transporter variants as well as two negative controls, E. coli BL21(DE3) and E. coli BL21(DE3) pSB1C3-PtNTT2, were cultivated in MOPS minimal media containing either 1,32 mM K2HPO4 or 1 mM ATP as sole phosphate source. Three biological replicates of each strain were cultivated in 1 mL of media in a 12 well plate at 37 °C and 600 rpm. For each measurement point, three technical replicates were measured. Figure 10 shows the growth curves of the cultivations carried out with 1,32 mM of K2HPO4 as the sole phosphate source.
Figure 10: Cultivation of all transporter variants in MOPS media with K2HPO4 acting as the sole phosphate source.
The cultivation was carried out in 12 well plates and three biological replicates were cultivated of each strain. For measurement of the optical density at 600 nm, three technical replicates were taken.
The cultivations were performed in parallel in MOPS media supplemented with 1 mM ATP as sole phosphate source. Again, three biological replicates of each strain were cultivated and three technical replicates measured for each time point. The growth curves are shown in Figure 11.
Figure 11: Cultivation of all strains in MOPS media with 1 mM ATP acting as the sole phosphate source.
Three biological replicates were cultivated and three technical replicates measured for each time point.
Table 7: Final OD600 values for all cultivations carried out in MOPS media with 1,32 mM K2HPO4.
Strain | Final OD600, K2HPO4 [-] | Final OD600, ATP [-] |
---|---|---|
E. coli BL21(DE3) | 2.923 ± 0.028 | 4.967 ± 0.143 |
E. coli BL21(DE3) pSB1C3-PtNTT2 | 3.507 ± 0.048 | 3.673 ± 0.091 |
E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2 | 1.537 ± 0.045 | 3.033 ± 0.028 |
E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2(66-575) | 3.560 ± 0.011 | 3.347 ± 0.032 |
E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2(31-575) | 3.797 ± 0.065 | 3.580 ± 0.006 |
E. coli BL21(DE3) pSB1C3-PlacUV5-pelB-SP-PtNTT2 | 3.907 ± 0.018 | 3.710 ± 0.177 |
E. coli BL21(DE3) pSB1C3-PlacUV5-TAT-SP-PtNTT2 | 3.307 ± 0.029 | 2.177 ± 0.007 |
Figure 12: Graphical determination of the maximum specific growth rates for all cultures cultivated in MOPS media with 1.32 mM K2HPO4.
Table 8: Maximum specific growth rates and minimal doubling times of the cultivations in MOPS media with 1.32 mM K2HPO4.
Strain | µmax [h-1] | td [h] |
---|---|---|
E. coli BL21(DE3) | 0.444 ± 0.053 | 1.561 ± 0.199 |
E. coli BL21(DE3) pSB1C3-PtNTT2 | 0.499 ± 0.050 | 1.389 ± 0.100 |
E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2 | 0.385 ± 0.044 | 1.800 ± 0.114 |
E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2(66-575) | 0,568 ± 0.057 | 1.220 ± 0.100 |
E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2(31-575) | 0.532 ± 0.022 | 1.303 ± 0.041 |
E. coli BL21(DE3) pSB1C3-PlacUV5-pelB-SP-PtNTT2 | 0.549 ± 0.017 | 1.263 ± 0.031 |
E. coli BL21(DE3) pSB1C3-PlacUV5-TAT-SP-PtNTT2 | 0.463 ± 0.028 | 1.497 ± 0.060 |
The graphical determination of the maximum specific growth rates of the cultures cultivated in ATP supplemented media is shown in Figure 13.
Figure 13: Graphical determination of the maximum specific growth rates of all cultivations performed in MOPS media and 1 mM ATP.
Table 9: Maximum specific growth rates and minimal doubling times of the cultivations in MOPS media with 1 mM ATP.
Strain | µmax [h-1] | td [h] |
---|---|---|
E. coli BL21(DE3) | 0.673 ± 0.012 | 1.030 ± 0.018 |
E. coli BL21(DE3) pSB1C3-PtNTT2 | 0.600 ± 0.021 | 1.155 ± 0.035 |
E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2 | 0.463 ± 0.035 | 1.497 ± 0.076 |
E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2(66-575) | 0.644 ± 0.069 | 1.076 ± 0.107 |
E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2(31-575) | 0.428 ± 0.091 | 1.620 ± 0.213 |
E. coli BL21(DE3) pSB1C3-PlacUV5-pelB-SP-PtNTT2 | 0.518 ± 0.043 | 1.338 ± 0.083 |
E. coli BL21(DE3) pSB1C3-PlacUV5-TAT-SP-PtNTT2 | 0.334 ± 0.047 | 2.075 ± 0.141 |
2
Figure 14: Relative beneficial effect of the different PtNTT2 variants.
As expected, the native transporter variant shows the highest positive effect since it most likely also exhibits the highest activity. Surprisingly, the two truncated versions show a higher effect than the versions with a pelB and TAT signal peptide.
This data suggests that the expression of different PtNTT2 variants, especially of the native PtNTT2, is beneficial for the cell when cultivated in MOPS minimal media supplemented with ATP as the sole phosphate source. Given that the reference strain does not express PtNTT2, the expression of PtNTT2 must have a beneficial effect for the cells since they grow better compared to the reference in ATP when compared to the reference in K2HPO4. Therefore, the beneficial effect is larger than the metabolic burden associated with recombinant protein expression. Consequently, the transporter exhibits a function beneficial to the cell in ATP supplemented media, meaning it can facilitate the direct uptake of ATP from the media. Therefore, the proposed activity of PtNTT2 in media supplemented with low concentrations of ATP could be verified.
Consequently, the same experiment was conducted with MOPS minimal media supplemented with 10 mM ATP. The relative beneficial effects of the experiment are summarized in Figure 15.
Figure 15: Relative beneficial effect of the different transporter variants when cultivated in MOPS minimal media supplemented with 10 mM ATP. No substantial beneficial effect could be observed for any of the transporter variants. The highest beneficial effects were reached by E. coli BL21(DE3) pSB1C3-PlacUV5-TAT-SP-PtNTT2 (+17.2 % ± 7.2 %) and E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2(31-575) (+14.0 % ± 4.7 %).
The experiment was repeated once again with MOPS media supplemented with 100 µM of iso-dCmTP and iso-dGTP. Substantial differences were observed for all transporter variants. PtNTT2(66-575) reached the highest beneficial effect with +38 % ± 10 %. All other transporter variants reached showed a negative effect compared to the reference. This confirms that ATP is exported in presence of the unnatural nucleotides, leading to a net loss of ATP and inhibition of growth. Therefore, it can be concluded that the native transporter variant PtNTT2 has the highest activity towards iso-dCmTP and iso-dGTP, followed by PtNTT2(31-575).
Figure 16: Relative beneficial effect of the best PtNTT2 variants cultivated in MOPS media supplemented with 100 µM of iso-dCmTP and iso-dGTP each. Substantial differences can be observed for all transporter variants, with PtNTT2(66-575) reaching the highest beneficial effect +38 % ± 10 %. All other transporter variants reached showed a negative effect compared to the reference, which means that ATP is exported in exchange for iso-dCmTP and iso-dGTP, leading to a net loss of ATP.
Figure 17: : Results of the LC-MS analysis of the supernatants of the cultures cultivated in MOPS media supplemented with 1 mM and 10 mM ATP. Measured AMP concentrations were standardized to the corresponding final optical densities.
Figure 18: Standard curve for AMP using 10 mM, 1 mM, 0.1 mM, 0.01 mM and 0.001 mM of AMP. The standard curve was used to quantify AMP in the supernatant of the cultivations carried out in ATP supplemented MOPS media.
Concluding, we were able to verify the function of PtNTT2 without using radioactively labeled nucleotides. The native transporter variant shows the highest activity in all experiments. Uptake of the unnatural nucleotides was verified by determination of the RBE of the different transporter variants when cultivated in MOPS media supplemented with the unnatural nucleotides. Since ATP is constantly exported in exchange for iso-dCmTP and iso-dGTP, leading to substantial negative influence on the growth of the cultures.
Subcellular Localization of PtNTT2
Figure 19: Confocal laser scanning microscopy of the different PtNTT2 variants fused to GFP (BBa_E0040). The pictures were taken with 100x magnification and show from A to E: E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2, E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2(66-575), E. coli BL21(DE3) pSB1C3-PlacUV5-PtNTT2(31-575), E. coli BL21(DE3) pSB1C3-PlacUV5-pelB-SP-PtNTT2 and E. coli BL21(DE3) pSB1C3-PlacUV5-TAT-SP-PtNTT2.
Isolation of PtNTT2 from the Inner Membrane
Figure 20: SDS-PAGE of the GFP-fusion constructs of PtNTT2
The cells were prepared using the fast cell lysis for SDS PAGE protocol. E. coli BL21(DE3) and E. coli BL21(DE3) pSB1C3-PtNTT2 were used as negative controls. Unsurprisingly, no thick band can be observed around 90.3 kDa, which would be the size of PtNTT2-cMyc-GFP. No bands can be observed for the other PtNTT2 variants.
Figure 21: Western Blot of the samples prepared using the fast cell lysis for SDS PAGE protocol.
An anti-GFP antibody was used for the detection of PtNTT2-cMyc-GFP variants. E . coli BL21(DE3) and E. coli BL21(DE3) pSB1C3-PtNTT2 were used as negative controls. Much unspecific binding of the anti-GFP antibody could be observed, which is not surprising given that the entire proteome of the cells was analyzed. Thick band can be observed for PtNTT2-cMyc-GFP, PtNTT2(66-575)-cMyc-GFP, PtNTT2(31-575)-cMyc-GFP and PtNTT2(pelB)-cMyc-GFP around 35 kDa. This indicates that only the cMyc-GFP linker was detected and that the linker might be cleaved of from PtNTT2 due to the high difference in hydrophobicity.
Figure 22: SDS PAGE performed with the isolated membrane fractions.
The cMyc-GFP fusion proteins were used, which should be visible around ~90 kDa, differing slightly based on the PtNTT2 variant used. No bands could be observed around 90 kDa, which was subsequently proofed by performing a Western Blot.
Figure 23: Western Blot of the isolated membrane fractions of the strains expressing the cMyc-GFP fusion proteins.
Thick bands can be observed around 28 kDa for all samples except for PtNTT2-cMyc-GFP with a TAT signal peptide. The negative controls do not show the same band, but some unspecific binding of the anti-GFP antibody could be observed. Compared to the previous Western Blot, unspecific binding was substantially reduced. These results indicate, that the linker is most likely separated from the transporter either during the isolation process or already within the cell. This would be no surprise, given that the transporter is highly hydrophobic while the linker is hydrophilic.
Figure 24: Western Blot of the isolated membrane fraction using an anti-cMyc antibody.
Again, fragments can be observed around 35 kDa for all samples except for PtNTT2-cMyc-GFP with a TAT signal peptide. No bands can be observed for the full construct, but a very weak band can be seen between 55 and 70 kDa for the fusion protein of the native transporter.
Figure 25: SDS PAGE of the isolated membrane fraction without previous boiling
No thick bands can be observed around 70 kDa. Slightly above 100 kDa, bands can be observed for all PtNTT2 variants but not for the negative controls. But given that the samples ran quite different on the gel compared to the boiled samples, no definite conclusion can be drawn from this gel.